Cargando…

An unusual concomitance of acute heart failure: prolactinoma in a patient with left ventricular dysfunction—a case report

BACKGROUND: Heart failure concomitant with prolactinoma is extremely rare. CASE SUMMARY: We present the case of a 29-year-old man who had acute decompensated heart failure concomitant with visual loss in his right eye. Transthoracic echocardiography indicated severely decreased left ventricular (LV)...

Descripción completa

Detalles Bibliográficos
Autores principales: Saito, Wataru, Idouji, Makoto, Shibue, Kimitaka, Ito, Shinya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10633695/
https://www.ncbi.nlm.nih.gov/pubmed/37954559
http://dx.doi.org/10.1093/ehjcr/ytad487
_version_ 1785132688423780352
author Saito, Wataru
Idouji, Makoto
Shibue, Kimitaka
Ito, Shinya
author_facet Saito, Wataru
Idouji, Makoto
Shibue, Kimitaka
Ito, Shinya
author_sort Saito, Wataru
collection PubMed
description BACKGROUND: Heart failure concomitant with prolactinoma is extremely rare. CASE SUMMARY: We present the case of a 29-year-old man who had acute decompensated heart failure concomitant with visual loss in his right eye. Transthoracic echocardiography indicated severely decreased left ventricular (LV) function. A massive tumour on the sella turcica was detected by brain computed tomography. The findings of the laboratory tests showed hyperprolactinaemia with hypopituitarism, and the antigen test for coronavirus disease 2019 was positive as an incidental finding. Medication for heart failure and cabergoline therapy were started immediately. His LV function significantly improved, and he had no symptoms after a year. DISCUSSION: Prolactinoma in men, which can cause visual loss and hypopituitarism, is frequently substantial when diagnosed. The cardiac manifestation of prolactinoma is uncommon. It is believed that a major contributing component to the pathogenesis of peripartum cardiomyopathy is hyperprolactinaemia. Hyperprolactinaemia may cause endothelial damage and cardiomyocyte dysfunction, eventually resulting in LV dysfunction. The success of LV reverse remodelling may be significantly impacted by heart failure and hormone treatments. Heart failure and endocrine therapy should be administered concurrently to patients who have prolactinoma and congestive heart failure.
format Online
Article
Text
id pubmed-10633695
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-106336952023-11-10 An unusual concomitance of acute heart failure: prolactinoma in a patient with left ventricular dysfunction—a case report Saito, Wataru Idouji, Makoto Shibue, Kimitaka Ito, Shinya Eur Heart J Case Rep Case Report BACKGROUND: Heart failure concomitant with prolactinoma is extremely rare. CASE SUMMARY: We present the case of a 29-year-old man who had acute decompensated heart failure concomitant with visual loss in his right eye. Transthoracic echocardiography indicated severely decreased left ventricular (LV) function. A massive tumour on the sella turcica was detected by brain computed tomography. The findings of the laboratory tests showed hyperprolactinaemia with hypopituitarism, and the antigen test for coronavirus disease 2019 was positive as an incidental finding. Medication for heart failure and cabergoline therapy were started immediately. His LV function significantly improved, and he had no symptoms after a year. DISCUSSION: Prolactinoma in men, which can cause visual loss and hypopituitarism, is frequently substantial when diagnosed. The cardiac manifestation of prolactinoma is uncommon. It is believed that a major contributing component to the pathogenesis of peripartum cardiomyopathy is hyperprolactinaemia. Hyperprolactinaemia may cause endothelial damage and cardiomyocyte dysfunction, eventually resulting in LV dysfunction. The success of LV reverse remodelling may be significantly impacted by heart failure and hormone treatments. Heart failure and endocrine therapy should be administered concurrently to patients who have prolactinoma and congestive heart failure. Oxford University Press 2023-10-04 /pmc/articles/PMC10633695/ /pubmed/37954559 http://dx.doi.org/10.1093/ehjcr/ytad487 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Case Report
Saito, Wataru
Idouji, Makoto
Shibue, Kimitaka
Ito, Shinya
An unusual concomitance of acute heart failure: prolactinoma in a patient with left ventricular dysfunction—a case report
title An unusual concomitance of acute heart failure: prolactinoma in a patient with left ventricular dysfunction—a case report
title_full An unusual concomitance of acute heart failure: prolactinoma in a patient with left ventricular dysfunction—a case report
title_fullStr An unusual concomitance of acute heart failure: prolactinoma in a patient with left ventricular dysfunction—a case report
title_full_unstemmed An unusual concomitance of acute heart failure: prolactinoma in a patient with left ventricular dysfunction—a case report
title_short An unusual concomitance of acute heart failure: prolactinoma in a patient with left ventricular dysfunction—a case report
title_sort unusual concomitance of acute heart failure: prolactinoma in a patient with left ventricular dysfunction—a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10633695/
https://www.ncbi.nlm.nih.gov/pubmed/37954559
http://dx.doi.org/10.1093/ehjcr/ytad487
work_keys_str_mv AT saitowataru anunusualconcomitanceofacuteheartfailureprolactinomainapatientwithleftventriculardysfunctionacasereport
AT idoujimakoto anunusualconcomitanceofacuteheartfailureprolactinomainapatientwithleftventriculardysfunctionacasereport
AT shibuekimitaka anunusualconcomitanceofacuteheartfailureprolactinomainapatientwithleftventriculardysfunctionacasereport
AT itoshinya anunusualconcomitanceofacuteheartfailureprolactinomainapatientwithleftventriculardysfunctionacasereport
AT saitowataru unusualconcomitanceofacuteheartfailureprolactinomainapatientwithleftventriculardysfunctionacasereport
AT idoujimakoto unusualconcomitanceofacuteheartfailureprolactinomainapatientwithleftventriculardysfunctionacasereport
AT shibuekimitaka unusualconcomitanceofacuteheartfailureprolactinomainapatientwithleftventriculardysfunctionacasereport
AT itoshinya unusualconcomitanceofacuteheartfailureprolactinomainapatientwithleftventriculardysfunctionacasereport